Home › Funds › QUANTIFY CHAOS ADVISORS, LLC › TVTX
QUANTIFY CHAOS ADVISORS, LLC position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
QUANTIFY CHAOS ADVISORS, LLC reported holding 16,527 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$973K, representing 2.20% of its reported portfolio and ranking #11 among its reported holdings. QUANTIFY CHAOS ADVISORS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR
How QUANTIFY CHAOS ADVISORS, LLC's TVTX position evolved
QUANTIFY CHAOS ADVISORS, LLC first disclosed a stake in TVTX in Q3 2026 at 16,527 shares (US$973K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 16.53K | $973.11K | New |
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $106.54M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $90.95M · Q2 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- Context Capital Management, LLC 50.50M sh · $59.46M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.03M sh · $58.63M · Q2 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $28.41M · Q2 2026
More on QUANTIFY CHAOS ADVISORS, LLC
FAQ
How long has QUANTIFY CHAOS ADVISORS, LLC held TVTX?
QUANTIFY CHAOS ADVISORS, LLC has disclosed TVTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is QUANTIFY CHAOS ADVISORS, LLC's current position in TVTX?
As of Q3 2026, QUANTIFY CHAOS ADVISORS, LLC holds 16.53K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $973.11K, representing 2.20% of its reported portfolio and ranking #11.
Has QUANTIFY CHAOS ADVISORS, LLC been buying or selling TVTX?
In the latest 13F filing (Q3 2026), QUANTIFY CHAOS ADVISORS, LLC newly opened its position in TVTX.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.